American Society of Clinical Oncology

SHERPA: White

People

  1. Drullinsky
    Drullinsky
  2. Hudis
    Hudis
  3. D'Andrea-Carlino
    D'Andrea-Carlino
  4. Dang
    Dang
  5. Fornier
    Fornier
  6. Norton
    Norton
  7. Sklarin
    Sklarin
  8. Sugarman
    Sugarman
  9. Troso-Sandoval
    Troso-Sandoval
  10. Comen
    Comen

Groups

  1. Breast Medicine Service (7)
  2. Department of Medicine (7)
  3. Solid Tumor Oncology Division (7)
  4. Survivorship Research (7)
  5. Biostatistics Service (6)
  6. Epidemiology and Biostatistics (6)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  8. Population Sciences Research Program (5)
  9. GDMT, Medicine (4)
  10. Gynecologic Medicine Service (4)
Search Within
  1. "Clifford Hudis"
  2. "Pamela Drullinsky"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Breast Medicine Service (7)
  2. Department of Medicine (7)
  3. Solid Tumor Oncology Division (7)
  4. Survivorship Research (7)
  5. Biostatistics Service (6)
  6. Epidemiology and Biostatistics (6)

More Groups

People
  1. Clifford Hudis (7)
  2. Pamela Drullinsky (7)
  3. Gabriella D'Andrea-Carlino (6)
  4. Sujata Patil (5)
  5. Chau Dang (4)
  6. Larry Norton (4)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2012 (1)
  4. 2011 (1)
  5. 2009 (1)
  6. 2008 (2)
Publications
  1. Journal of Clinical Oncology (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Meeting Abstract

    Conlin, A. K.; D'Andrea, G.; Hudis, C. A.; Robson, M. E.; Drullinsky, P.; Theodoulou, M.; Lis, E.; Kang, T. Y.; Peereboom, D. M.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save